When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AKCA - Akcea's Tegsedi shows sustained benefit in hATTR extension study
Akcea Therapeutics Inc.
Ionis Pharmaceuticals (NASDAQ:IONS) majority-owned affiliate Akcea Therapeutics (NASDAQ:AKCA) announces the publication of long-term data from the NEURO-TTR study evaluating Tegsedi (inotersen) in patients with hereditary transthyretin (hATTR) amyloidosis with polyneuropathy. The results are in the latest edition of the European Journal of Neurology.
More news on: Ionis Pharmaceuticals, Inc., Akcea Therapeutics, Inc., Healthcare stocks news,